0001104659-20-012712.txt : 20200207 0001104659-20-012712.hdr.sgml : 20200207 20200207200859 ACCESSION NUMBER: 0001104659-20-012712 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200205 FILED AS OF DATE: 20200207 DATE AS OF CHANGE: 20200207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shandell Jason B. CENTRAL INDEX KEY: 0001611148 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 20589014 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330702205 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 4 1 a4.xml 4 X0306 4 2020-02-05 0 0001297184 Amphastar Pharmaceuticals, Inc. AMPH 0001611148 Shandell Jason B. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 0 0 President and General Counsel Common Stock 2020-02-05 4 M 0 15615 14.40 A 154513 D Common Stock 2020-02-05 4 S 0 15615 19.568 D 138898 D Common Stock 2020-02-06 4 M 0 21933 14.40 A 160831 D Common Stock 2020-02-06 4 S 0 21933 19.8309 D 138898 D Common Stock 2020-02-07 4 M 0 6853 14.40 A 145751 D Common Stock 2020-02-07 4 S 0 6853 19.8832 D 138898 D Employee Stock Option (right to buy) 14.40 2020-02-05 4 M 0 15615 0 D 2024-03-27 Common Stock 15615 75730 D Employee Stock Option (right to buy) 14.40 2020-02-06 4 M 0 21933 0 D 2024-03-27 Common Stock 21933 53797 D Employee Stock Option (right to buy) 14.40 2020-02-07 4 M 0 6853 0 D 2024-03-27 Common Stock 6853 46944 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2019. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.35 to $19.77 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $19.58 to $19.99, inclusive. The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $19.83 to $20.00, inclusive. Shares subject to the option are fully vested and immediately exercisable. /s/ Eva Wen, by power of attorney 2020-02-07